Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (271-280 of 425) with videos related to

Pageof 43
Sort By:
Journal of Clinical Lipidology|April 25, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, et al.
Experimental and Therapeutic Medicine|December 28, 2020
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review)Roxana Adriana Stoica, Camelia Cristina Diaconu, Manfredi Rizzo, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
Annals of Internal Medicine|October 25, 2016
Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive CardiologyStephen L Kopecky, Douglas C Bauer, Martha Gulati, et al.
AIDS (London, England)|January 26, 2017
Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patientsParag H Joshi, P Elliott Miller, Seth S Martin, et al.
European Journal of Preventive Cardiology|July 12, 2019
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC studyRenato Quispe, Mohamed B Elshazly, Di Zhao, et al.
The American Journal of Cardiology|October 21, 2016
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic HypercholesterolemiaPeter P Toth, Alberico L Catapano, Michel Farnier, et al.
Thyroid : Official Journal of the American Thyroid Association|August 3, 2023
GlycA as a Novel Biomarker of Systemic Inflammation in HypothyroidismSarah Galvao, Isabela M Bensenor, Michael J Blaha, et al.
Diabetes, Obesity & Metabolism|June 12, 2018
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)Jean Ferrières, Dominik Lautsch, Anselm K Gitt, et al.
European Journal of Clinical Investigation|June 8, 2024
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohortYang Chen, Ying Gue, Maciej Banach, et al.
Pageof 43

Showing results (271-280 of 425) with videos related to

Sort By:
Pageof 43
Journal of Clinical Lipidology|April 25, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, et al.
Experimental and Therapeutic Medicine|December 28, 2020
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review)Roxana Adriana Stoica, Camelia Cristina Diaconu, Manfredi Rizzo, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
Annals of Internal Medicine|October 25, 2016
Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive CardiologyStephen L Kopecky, Douglas C Bauer, Martha Gulati, et al.
AIDS (London, England)|January 26, 2017
Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patientsParag H Joshi, P Elliott Miller, Seth S Martin, et al.
European Journal of Preventive Cardiology|July 12, 2019
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC studyRenato Quispe, Mohamed B Elshazly, Di Zhao, et al.
The American Journal of Cardiology|October 21, 2016
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic HypercholesterolemiaPeter P Toth, Alberico L Catapano, Michel Farnier, et al.
Thyroid : Official Journal of the American Thyroid Association|August 3, 2023
GlycA as a Novel Biomarker of Systemic Inflammation in HypothyroidismSarah Galvao, Isabela M Bensenor, Michael J Blaha, et al.
Diabetes, Obesity & Metabolism|June 12, 2018
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)Jean Ferrières, Dominik Lautsch, Anselm K Gitt, et al.
European Journal of Clinical Investigation|June 8, 2024
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohortYang Chen, Ying Gue, Maciej Banach, et al.
Pageof 43